Rating History for Black Diamond Therapeutics (BDTX) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for BDTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/3/2025 Bradley Canino Downgrade Neutral
(Buy)		 N/A
(N/A)		 3.45
(1.61)		 -53.33% Details